Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Sterility Testing in Aseptic Transdermal Patches

Posted on By

SOP for Sterility Testing in Aseptic Transdermal Patches

Standard Operating Procedure for Sterility Testing in Aseptic Transdermal Patches

1) Purpose

To establish a standardized procedure for conducting sterility testing in aseptic transdermal patches to ensure they are free from viable contaminating microorganisms.

2) Scope

This SOP applies to the quality control (QC) and quality assurance (QA) departments responsible for sterility testing of aseptic transdermal patches.

3) Responsibilities

3.1 QC Analysts: Perform sterility tests according to the procedure.
3.2 QA Personnel: Review and approve test results and ensure compliance with the SOP.
3.3 Production Personnel: Provide samples and relevant documentation for testing.
3.4 Regulatory Affairs: Ensure that the sterility testing procedure complies with regulatory requirements.

See also  SOP for Product Development for New Transdermal Patch Formulations

4) Procedure

4.1 Preparation:

4.1.1 Collect samples of aseptic transdermal patches from the production batch as per the sampling plan.

4.1.2 Ensure all equipment and materials used for sterility testing are sterilized and ready for use.

4.2 Sterility Testing:
4.2.1 Sample Preparation:

4.2.1.1 Aseptically remove patches from their packaging.

4.2.1.2 Cut a representative sample of the patch for testing, if applicable.

4.2.2 Test Execution:

4.2.2.1 Use aseptic techniques to place the sample into a sterile culture medium (e.g., Soybean-Casein Digest Medium).

4.2.2.2 Incubate the samples at 20-25°C for 14 days or as specified in the test method.

4.2.2.3 Observe the samples regularly for signs of microbial growth.

See also  SOP for Change Control in Transdermal Patches Production

4.2.3 Post-Test Evaluation:

4.2.3.1 After the incubation period, check the culture media for turbidity or other signs of microbial growth.

4.2.3.2 Record any positive results and identify the type of microorganism if growth is observed.

4.2.3.3 Document all observations and results accurately in the test records.

4.3 Acceptance Criteria:

4.3.1 Define acceptance criteria for sterility based on regulatory guidelines and product specifications.

4.3.2 Ensure that the transdermal patches meet the defined criteria before they are approved for release.

4.4 Documentation:

4.4.1 Record all test results, including test conditions, observations, and outcomes.

4.4.2 Maintain records of equipment calibration and maintenance.

4.5 Review and Approval:

See also  SOP for Application Site Testing for Transdermal Patches

4.5.1 QA personnel review test results for compliance with acceptance criteria.

4.5.2 Approve or reject batches based on test outcomes.

4.5.3 Ensure all documentation is complete and accurate before batch release.

5) Abbreviations, if any

SOP: Standard Operating Procedure
QC: Quality Control
QA: Quality Assurance

6) Documents, if any

Sterility Test Records
Calibration Records
Test Method Protocols
Batch Manufacturing Records

7) Reference, if any

USP Chapter 71: Sterility Tests
ICH Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients

8) SOP Version

Version 1.0

Transdermal Patches Tags:Adhesion Testing Protocol, Analytical Method Development SOP, Assay of Active Ingredient SOP, Contamination Prevention SOP, Documentation SOP, Equipment calibration SOP, Equipment Cleaning SOP, Final Product Inspection SOP, Formulation development SOP, Homogeneity Testing SOP, In-process Testing SOP, Microbial Testing SOP, Personnel Training SOP, Process Optimization SOP, Process Validation SOP, Quality Control Transdermal Patches, Raw Material Inspection SOP, Release Rate Testing SOP, Sample Collection SOP, Sterility Maintenance SOP, Storage Conditions Transdermal Patches, Thickness Testing Procedure, Transdermal Patch Manufacturing SOP, Transdermal Patch Stability Testing, Waste Handling SOP

Post navigation

Previous Post: SOP for Stability Testing of IM and SC Products
Next Post: SOP for Cream Emulsifier

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version